Increased body mass index after H. pylori eradication for duodenal ulcer predisposes to erosive reflux esophagitis

J Clin Gastroenterol. 2009 Sep;43(8):705-10. doi: 10.1097/MCG.0b013e3181948c45.

Abstract

Background: A higher body mass index (BMI) may lead to a more adverse outcome of reflux esophagitis. The study aimed to determine whether increased BMI after H. pylori eradication in duodenal ulcer patients predisposes to erosive reflux esophagitis.

Methods: Four hundred fifty-nine patients with Helicobacter pylori-positive duodenal ulcers but without reflux esophagitis were evaluated. Serial BMIs were collected before therapy and on the 2nd, 6th, and 12th months after H. pylori eradication. New-onset reflux esophagitis was recorded.

Results: In 350 patients with complete follow-up, mean BMI increased from the second month after H. pylori eradication (P<0.001). H. pylori eradication also led to a net increase of BMI >1.5 kg/m in nearly 20% of patients in the 12-month follow-up, whereas new-onset of reflux esophagitis was noted in 16.3% (57/350). Baseline BMI, prevalence rate of hiatus hernia, and net increase of BMI were higher in patients with new-onset reflux than in those without (P<0.05). Multiple logistic regression confirmed higher baseline BMI, hiatus hernia, and net BMI increase >1.5 kg/m after H. pylori eradication were independently associated with new-onset reflux esophagitis (P<0.05).

Conclusions: Eradication of H. pylori may lead to a significant net increase of BMI in patients with duodenal ulcers. Such BMI gain, as well as higher baseline BMI and hiatus hernia, predisposes to new-onset reflux esophagitis after H. pylori eradication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Body Mass Index*
  • Duodenal Ulcer / complications*
  • Duodenal Ulcer / drug therapy
  • Duodenal Ulcer / microbiology
  • Esophagitis, Peptic / diagnosis
  • Esophagitis, Peptic / epidemiology
  • Esophagitis, Peptic / etiology*
  • Female
  • Helicobacter Infections / complications*
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / microbiology
  • Helicobacter pylori* / drug effects
  • Hernia, Hiatal / complications
  • Hernia, Hiatal / epidemiology
  • Humans
  • Male
  • Prevalence
  • Risk Assessment
  • Risk Factors